Is Hims & Hers rally at risk as GLP-1 shortages ease?
WEB1 day ago · With no downgrades on the stock since August, Wall Street analysts agree. "HIMS is not just a GLP-1 story," Needham argued recently, launching its coverage with a Buy recommendation and a $24 ...
Hims & Hers Health Stock Falls as FDA Drops Eli Lilly
WEB1 day ago · Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration (FDA) said Eli Lilly's popular weight-loss drugs are no longer on its list of drugs in short supply. The FDA ...
Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: …
WEB2 days ago · In the latest market close, Hims & Hers Health, Inc. (HIMS) reached $18.95, with a -1.86% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.01%.
Hims & Hers Health, Inc. (HIMS) Latest Stock News & Headlines …
WEBGet the latest Hims & Hers Health, Inc. (HIMS) stock news and headlines to help you in your trading and investing decisions.
Hims & Hers Newsroom
WEBHims & Hers Launches Latest Compounded 2-in-1 Medication: Sex Rx + Climax Control. April 17, 2024.
Hims & Hers Health, Inc. (HIMS) Stock Price, News, Quote
WEBFind the latest Hims & Hers Health, Inc. (HIMS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
WEBMay 6, 2024 · SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2024 in a shareholder letter that is posted at investors.hims.com.
News Details - Hims
WEBJuly 31, 2023. One in four U.S. men die of heart disease. Hims aims to expand access to preventive care with new dual-action capabilities that support sexual health and the heart together, signaling the company’s next frontier of personalized health and wellness.
Hims & Hers Stock Pops After Massive Acquisition
WEBSep 13, 2024 · Shares of healthcare company Hims & Hers Health (HIMS 0.34%) jumped as much as 23.9% this week after news of closing a large acquisition. According to data provided by S&P Global Market ...
Hims & Hers weight loss adds compounded GLP-1 injections
WEBMay 20, 2024 · Digital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections. The GLP-1 market, dominated so far by pharmaceutical giant Novo Nordisk, has faced...